Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.
about
Immunomodulatory functions of type I interferonsInflammasome in intestinal inflammation and cancerToll-like receptors in pathophysiology of liver diseasesHVEM signalling at mucosal barriers provides host defence against pathogenic bacteriaCaspase-1 activation via Rho GTPases: a common theme in mucosal infections?MyD88 signaling in dendritic cells and the intestinal epithelium controls immunity against intestinal infection with C. rodentium.Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis.NOD-like receptors in intestinal homeostasis and epithelial tissue repair.Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.Altering host resistance to infections through microbial transplantation.Deregulated inflammasome signaling in disease.The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitisInterleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.The Nlrp3 inflammasome: contributions to intestinal homeostasis.Epithelial phosphatidylinositol-3-kinase signaling is required for β-catenin activation and host defense against Citrobacter rodentium infection.SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.A balanced IL-1β activity is required for host response to Citrobacter rodentium infection.Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophagesSIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis.NF-κB in the regulation of epithelial homeostasis and inflammation.Host innate recognition of an intestinal bacterial pathogen induces TRIF-dependent protective immunity.The epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation.The role of innate immunity in the host defense against intestinal bacterial pathogens.Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection.Functions of innate immune cells and commensal bacteria in gut homeostasis.The role of phosphoinositide 3-kinase signaling in intestinal inflammationGeneration of a Novel T Cell Specific Interleukin-1 Receptor Type 1 Conditional Knock Out Mouse Reveals Intrinsic Defects in Survival, Expansion and Cytokine Production of CD4 T Cells.HVEM: An unusual TNF receptor family member important for mucosal innate immune responses to microbes.Precarious balance: Th17 cells in host defense.An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer.Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance.Inflammasomes in carcinogenesis and anticancer immune responses.Interactions between Nod-Like Receptors and Intestinal Bacteria.Role of inflammasomes in intestinal inflammation and Crohn's disease.Protective and detrimental roles of inflammasomes in disease.IL-1RT1 signaling antagonizes IL-11 induced STAT3 dependent cardiac and antral stomach tumor development through myeloid cell enrichment.Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis.
P2860
Q26823904-A73B0825-9081-4872-AFE8-48878D115F16Q27026882-CED4A652-5EAB-47F6-8A74-7A6E638B0A51Q28070077-128E55D1-B9F0-49B0-A869-717F5D1503BBQ28590892-BF5B31AC-C55F-4CAF-9CFD-E21D7399EC46Q33535907-4E64D21E-F41C-4519-9D57-F7726F97F2A4Q33693973-23528F99-38CF-4F97-A611-1A83BC52298BQ33728144-CAE609AC-393C-40EC-9C0D-DD1F0072A794Q33907548-99160717-DF80-40B1-956F-4509EF1B1B3EQ33967100-44CBEF8F-C0E5-4A3A-9C72-D47EB0869A2FQ34064885-83BD3AC8-9C02-49BF-9BED-558FFBB7C56BQ34212591-782655A9-0637-4815-98B4-87765383A448Q34313840-B02F024E-5FAC-416F-A3E9-CCDE911563A2Q34381495-0FE62434-24FC-432F-BE25-0B90828ED2B5Q34420855-90B7DA8D-C620-4B8E-AD84-4F9A38DFCE51Q34484529-FF180055-D265-419E-B9FA-2F7BFB9B5152Q34762033-A6845C27-B1DF-4CD7-AE20-29945E0D11F0Q34931410-C70C73F9-38AA-4FD2-95D8-851D821A6549Q34945452-9AE30D73-C529-4060-97E8-65A00ABDDC47Q35061095-46B5B05C-AE43-44F8-92A8-B29F71B9CEB1Q35072031-4C77CBA2-E191-437C-A7EB-BC32A1B8A95FQ35128167-DB6D1E9F-119D-495C-8614-7A5758755078Q35302843-396C3789-9960-496E-8EF9-53FE7ADAABC3Q35347805-E81B67CD-FF2D-4106-91EC-BE81CAA8B5AAQ35627724-B5CD2AD2-456D-4179-8CE1-BF1B77077949Q35669042-829A277D-61E5-4169-A9E6-4213630133DFQ35740637-A0F5C740-6136-43FA-961D-535015FC4FACQ35833796-5FD59959-CD4F-49B7-A6F7-92DBFF3BE32CQ35854795-AC77B2D8-D629-422D-B89B-2E8713FEF245Q35915458-27A9C625-F053-4A85-9D03-07F4B13752A8Q36110216-DEBFA779-1F65-4B34-B758-6B57F9A3A96CQ36677090-D9FBB5B7-9A14-4FFF-8A9E-DD4D8312EC6DQ37630095-479F2487-58DC-4537-9E8C-4F8CAF8D59D8Q37777272-3C8C92AE-5744-4E80-BE49-8A77BDF6CF4DQ37974695-0E650E0F-F548-46C5-B675-DC6EF30F9775Q37995072-526D111F-1053-4CD1-9C0E-0BDC03562B2AQ38175027-3DAFFA2A-B129-4F69-A7BB-EE361747A7A8Q38291767-D424F343-DE12-4DFE-A774-8D0C199F9541Q38431249-27575948-3A6F-487A-87E2-E557DC08D26EQ38926655-24707706-5E19-4C60-A4FF-FBAFE24CC1A9Q39009516-41D2E42C-767D-48BD-8937-62C3906294FB
P2860
Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@en
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@nl
type
label
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@en
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@nl
prefLabel
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@en
Interleukin-1 receptor signali ...... athogen Citrobacter rodentium.
@nl
P2093
P2860
P356
P1476
Interleukin-1 receptor signali ...... pathogen Citrobacter rodentium
@en
P2093
Daniel Kalman
Didier Merlin
Melanie A Sherman
Sarah L Lebeis
P2860
P304
P356
10.1128/IAI.00907-08
P407
P577
2008-12-15T00:00:00Z